Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Bristol-Myers sets up program for heart attack prevention

Sep. 20, 1996

Pierre Fabre investigates ACAT inhibitors

Sep. 20, 1996

Prevention of bone loss with alendronate

Sep. 20, 1996

Endocrine research at Toyama

Sep. 13, 1996

Endocrine R&D at Chugai

Sep. 13, 1996

A safe, effective and economical contraceptive method

Sep. 13, 1996

Danish approval for testosterone patch

Sep. 13, 1996

Orally active GH secretagogues with a short duration of action

Sep. 13, 1996

New treatment for diabetic keratopathy

Sep. 13, 1996

Achiral inhibitors of carnitine palmitoyltransferase I

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...